Efficiency of Multiparticulate Delivery Systems Loaded with Flufenamic Acid Designed for Burn Wound Healing Applications

Figure 5

The drug kinetic release mechanism form of different topical delivery systems: (a) spongious matrix with an anti-inflammatory drug incorporated in a free form—M1; (b) multiparticulate delivery systems like the spongious matrix with an anti-inflammatory drug incorporated in an encapsulated form—M2 and M3; (c) multiparticulate delivery systems like the spongious matrix with an anti-inflammatory drug incorporated in a free form and encapsulated form—M4 and M5.